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Abstract
Background: The Tissue Microarray (TMA) facilitates high-throughput analysis of hundreds of tissue specimens simultaneously.
However, bottlenecks in the storage and manipulation of the data generated from TMA reviews have become apparent. A
number of software applications have been developed to assist in image and data management; however no solution currently
facilitates the easy online review, scoring and subsequent storage of images and data associated with TMA experimentation.
Results: This paper describes the design, development and validation of the Virtual Tissue Matrix (VTM). Through an intuitive
HTML driven user interface, the VTM provides digital/virtual slide based images of each TMA core and a means to record
observations on each TMA spot. Data generated from a TMA review is stored in an associated relational database, which
facilitates the use of flexible scoring forms. The system allows multiple users to record their interpretation of each TMA spot
for any parameters assessed. Images generated for the VTM were captured using a standard background lighting intensity and
corrective algorithms were applied to each image to eliminate any background lighting hue inconsistencies or vignetting.
Validation of the VTM involved examination of inter-and intra-observer variability between microscope and digital TMA reviews.
Six bladder TMAs were immunohistochemically stained for E-Cadherin, β-Catenin and PhosphoMet and were assessed by two
reviewers for the amount of core and tumour present, the amount and intensity of membrane, cytoplasmic and nuclear staining.
Conclusion: Results show that digital VTM images are representative of the original tissue viewed with a microscope. There
were equivalent levels of inter-and intra-observer agreement for five out of the eight parameters assessed. Results also suggest
that digital reviews may correct potential problems experienced when reviewing TMAs using a microscope, for example,
removal of background lighting variance and tint, and potential disorientation of the reviewer, which may have resulted in the
discrepancies evident in the remaining three parameters.
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Background
Tissue Microarrays (TMAs) provide high-throughput anal-
ysis of tissue samples for in situ hybridisation and immu-
nohistochemistry, by means of arranging multiple tissue
samples in a uniform structure on the surface of a glass
slide. TMAs allow for large numbers of tissue samples to
be analysed simultaneously at DNA, RNA or protein level.
Kononen et al. first illustrated the use of TMAs in 1998 [1].
The technique involves the excision of cores of varying
diameter (0.6 mm to 2 mm) from regions of histological
importance on donor tissue blocks and the subsequent
insertion of these excised cores into precise co-ordinates
on a recipient block. This process is repeated until a two-
dimensional matrix of cores is inserted into the recipient
block. Once the block is complete, sections can be cut
from the block, which are then available for any analysis
currently performed on full-face tissue sections.
A large amount of data is associated with TMAs, ranging
from information on the tissue (patient information), to
their construction, subsequent staining and assessment. It
was becoming apparent that applications to assist in
pathologist's reviews of TMAs are required, as bottlenecks
in the storage and manipulation of the data generated are
beginning to emerge.
There have been previous attempts to create software
applications that facilitate review of TMAs [2]. The tech-
nology has varied from using Microsoft Excel™ spread-
sheets, to the creation of complex databases. Manley et al.
(2001) developed a relational database to store data and
images, which focus on clinical outcome [3]. This system
consisted of several databases to store TMA images, TMA
information, pathological and clinical information, in
Microsoft Access™. All data was manually entered into a
main online form and then transferred into the relevant
database table. Each image was scanned using a grid struc-
ture that overlaid the image of the array. The images were
composed of six separate 10 × fields, stitched together to
form a single image, which was saved as a JPEG image
(200–300 kb). However, despite the advances made by
this system, rapid file sharing over the internet was limited
by large image sizes with slow internet connections. Also,
as the software utilised were commercial applications,
adaptations to the functionality of the programs were not
possible.
Liu et al. (2002) utilised a combination of commercial
and in-house applications to store data, digitise images
and perform statistical analysis [4]. Information was
stored in Microsoft Excel™ spreadsheets and reformatted
by a program called TMA deconvoluter, into a structure
that can be further manipulated to allow statistical analy-
sis and hierarchical clustering. Although Microsoft Excel™
spreadsheets are traditionally used by scientists to store
data, there is always a significant risk of human error, as
large amounts of data entry are required and the object-
oriented nature of the data does not lead to optimal data
storage in spreadsheets.
The ability to interpret, review and grade histology in TMA
images across the Internet was assessed by Bova et al. [5].
This study evaluated the reviewer's ability to interpret
images of TMA cores, in order to assess the presence or
absence of prostate cancer and to Gleason grade tumours.
In 99% of cases, the images were deemed interpretable;
this was done by visual inspection. However, it was sug-
gested that on occasion lengthy downloading times
would limit the system's practical use. The authors recom-
mended that compressed files of less than 200 kb should
be evaluated for viable image quality, as using files of this
size would reduce downloading times. Inter-and intra-
observer variability was found to be no greater, and in
some cases less than, that reported when using traditional
microscope-based Gleason grading. This was evaluated by
comparing the Inter-and intra-observer variability
observed in Bova et al. study of on line analysis with those
previously reported in literature for Inter-and intra-
observer of TMA glass slide analysis. When evaluating lev-
els of inter-and intra-observer agreement, Bova et al. used
percentage of complete agreement, and k coefficient of
agreement. They concluded that web-based technology
was an acceptable means to review TMAs. The authors
believed a limitation of their study was that web-based
analysis was not directly compared with their microscope-
based review. The authors recommended that this tech-
nology be tested using data resulting from immunohisto-
chemical and in situ hybridisation reviews.
The advent of virtual slides permitted the review of whole
tissue slides across the Internet [6]. Virtual slides provide
users all the functionality of a microscope, but with
numerous additional benefits, including concurrent
access for multiple users, tracking of review movements
and image annotation. Virtual slides are reminiscent of
microscope use, they are favoured by pathologists over
static digital images, due to the ability to change magnifi-
cation and scroll laterally while reviewing the image.
The aim of this study was to develop and validate a soft-
ware application that would combine the benefits of vir-
tual slides and online relational database technology, to
facilitate TMA reviews and scoring via the Internet. To val-
idate the software system developed, a study was created
to ensure the system could achieve comparable results to
those obtained from traditional glass slide analysis. The
study examined users' ability to agree when performing
virtual and glass reviews of six immunohistochemically
stained tissue microarrays, across eight parameters.BMC Bioinformatics 2006, 7:256 http://www.biomedcentral.com/1471-2105/7/256
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Results
Two reviewers (Users A and B) examined 183 TMA spots
(196 minus 12 control spots and one un-reviewed spot)
stained with 3 immunostains using both review methods
(microscope and VTM). Neither user reported any techni-
cal difficulties when performing digital or microscope
analysis. The levels of intra-and inter-observer variability
between digital and microscope TMA reviews were
assessed, for parameters examining the amount of core
and tumour present, the amount and intensity of mem-
brane, cytoplasmic and nuclear staining.
Table 1 illustrates the intra-observer variability between
virtual and glass TMA reviews. Good levels of agreement
(>60%) between methods were observed when quantify-
ing the amount of core present, the amount of membrane,
nuclear and cytoplasmic staining and nuclear intensity.
Low levels of agreement between methods were observed
when quantifying the amount of tumour present and
membrane intensity.
Table 1 illustrates the inter-observer agreement achieved
when performing both virtual and glass TMA reviews.
Inter-observer agreements achieved when performing vir-
tual TMA reviews were comparable with inter-observer
agreements achieved when performing glass TMA reviews,
for four out of eight parameters. The Virtual TMA review
of the amount of tumour present achieved greater levels of
inter-observer agreement than the glass TMA review, of
this parameter, however the level of agreement between
users for this parameter was very low for both methods of
assessment. The glass TMA review of the amount of cyto-
plasmic staining and intensity, and membrane staining
intensity achieved greater levels of inter-observer agree-
ment than the virtual TMA review, of these parameters.
The parameter, % Tumour present, was difficult to assess,
with low agreement recorded for inter-and intra-observer
agreements across virtual and glass TMA reviews. As this
parameter has equivalent levels of inter-observer variabil-
ity for both virtual and glass TMA reviews, it has to be
assumed that poor performance is not based on the
method, but more likely the size of the range used. A 10%
interval was used to quantify the amount of tumour
present, which appears too constrained for this parameter.
Reviewers found quantification of the parameter mem-
brane intensity difficult to reproduce between virtual and
glass TMA reviews. When users assessed membrane inten-
sity using a microscope, they predominantly used two cat-
egories of staining intensity, negative and moderate. With
the virtual TMA review, users appeared to use the classifier
more extensively, as illustrated in Figure 1. The assessment
of intensity of immunohistochemistry, particularly the
intensity of membrane bound immunostains is inher-
ently difficult. For example, problems with Her-2 assess-
ment by immunohistochemistry are well documented
[7,8].
Discussion
The objective of this study was to design and develop an
online software application that presents tissue microar-
ray images and stores associated review and clinical data.
The result was the Virtual Tissue Matrix (VTM), which con-
sists of TMA images available at multiple magnifications,
scoring forms to gather TMA review data and a relational
database to store the generated results.
The VTM displays virtual TMA images via a web site and
facilitates the storage of TMA data via a relational data-
base. There are numerous advantages of using the VTM
over other proposed software systems of its type. Down-
loading of the images is rapid. Only views that are
requested by the user are returned at maximum resolu-
tion, thereby downloading the minimum required data-
set. The VTM was designed in consultation with scientists
and pathologists and, as a result, the reviewing process
emulates the workflow involved in conventional TMA
Table 1: Agreement levels (%) and un-weighted kappa values by measured parameter for each comparison of TMA reviews.
Parameters Virtual vs. Glass User A vs. B Virtual User A vs. B Glass
% Agree Kappa % Agree Kappa % Agree Kappa
% Core Present 71.3 0.507 67.1 0.414 67.4 0.448
% Tumour Present 47.3 0.407 37.9 0.283 33.0 0.244
% Membrane Staining 81.2 0.577 78.2 0.553 78.6 0.520
% Cytoplasmic Staining 64.0 0.3734 2 . 8 0.198 65.9 0.280
% Nuclear Staining 85.0 0.226 84.9 0.524 95.8 0.239
Membrane Intensity 32.4 0.167 25.3 0.153 77.1 0.447
Cytoplasmic Intensity 58.2 0.306 50.8 0.263 65.2 0.234
Nuclear Intensity 82.1 0.109 83.3 0.474 89.2 0.234
Virtual vs. Glass was the average of two users' agreements when comparing virtual with glass TMA reviews. User A vs. B Virtual was User A virtual 
TMA review compared with User B virtual TMA review. User A vs. B Glass was User A glass TMA review compared with User B glass TMA 
review.BMC Bioinformatics 2006, 7:256 http://www.biomedcentral.com/1471-2105/7/256
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Distribution of the results for virtual and glass TMA reviews of cytoplasmic and membrane staining intensity and cytoplasmic  staining Figure 1
Distribution of the results for virtual and glass TMA reviews of cytoplasmic and membrane staining intensity 
and cytoplasmic staining. Illustrates the distribution of the classifiers when using virtual and glass methods to (1A) Amount 
of cytoplasmic staining performed by glass TMA review (1B) Amount of cytoplasmic staining performed by virtual TMA review 
(2A) Cytoplasmic staining intensity performed by glass TMA review (2B) Cytoplasmic staining intensity performed by virtual 
TMA review (3A) Membrane staining intensity performed by glass TMA review (3B) Membrane staining intensity performed by 
virtual TMA review.BMC Bioinformatics 2006, 7:256 http://www.biomedcentral.com/1471-2105/7/256
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reviews. The VTM interface is delivered in HTML, via a
conventional web browser, allowing for intuitive user
interaction. The VTM database is relational; a structure
more suited to the storage of the object oriented dataset
generated from TMA experimentation, than previous
efforts incorporating flat files and spreadsheets for data
storage.
Since the creation of the VTM there have been numerous
advances in the technologies used for image acquisition
[9-11] and image analysis techniques and applications
have been well documented in literature [12-17]. Inte-
grated intuitive systems are now available that rely on
minimal human intervention when scanning slides such
as Aperio or Dmetrix [18]. Numerous commercial image
acquisition applications are now available[19-21]; how-
ever, cost of purchase is often high for these integrated sys-
tems putting them out of reach for many research
laboratories.
The VTM has been upgraded to support images generated
by an Aperio Scanscope T3 Scanner™. Advantages of using
the Aperio Scanscope T3 Scanner™ include, batch upload-
ing of slides, the ability to scan glass TMA slides at 20 ×
magnification within minutes, one touch scanning which
reduces manual intervention, automatic section of auto-
focus points within the tissue, and seamless images with
no tiling artifacts. Despite the advances in image acquisi-
tion and the obvious advantages automated systems have
over older more labour intensive systems, these systems
do not wholly address the problem of relating TMA
images to review and image analysis data.
The method used to acquire digital images within the
VTM is not the main concern of this manuscript, the tech-
nology is constantly developing and advancing, and as
new and improved systems are developed they can be
integrated into the VTM with ease as illustrated by the
upgrade to Aperio™.
Once developed the VTM was validated, via assessment of
inter-and intra-observer variability on two users' evalua-
tions of immunohistochemically stained tissue microar-
rays, using digital and microscope analysis. Eight
parameters were evaluated, the amount of core and
tumour present, the amount and intensity of membrane,
cytoplasmic and nuclear staining.
Comparisons evaluated in this study illustrated that intra-
and inter-observer virtual TMA reviews produced equiva-
lent levels of agreement as intra-and inter-observer glass
TMA reviews, for five out of the eight parameters exam-
ined. Where discrepancies occurred it was dependent on
the parameters and users involved.  In all comparisons,
low levels of agreement for the amount of tumour present
were observed. This was not surprising, as the application
of classifiers to any data continuum (data that does not
naturally fall into discrete clusters) results in scoring vari-
ability around the interfaces of the classifier. This variabil-
ity is increased when the number of classes are increased
creating more interfaces. Also, of the two reviewers used,
one was a scientist and one a pathologist. The scientist
accurate interpretation of tumour/non tumour may
potentially be questioned as a result of this work.
Of particular interest, were a large number of observations
that were considered positively stained by virtual TMA
reviews which were considered negatively stained when
reviewed using a microscope. This was particularly evi-
dent when quantifying the amount of cytoplasmic stain-
ing; where virtual TMA reviews observed substantially
more positively stained spots than glass TMA reviews. The
additional positively stained spots were largely considered
to stain between 1–30% of the tumour area and/or to be
weakly stained. This suggests that virtual TMA reviews
may be more successful in allowing the identification of
small areas of staining and/or where staining intensity is
low.
One proposed reason for the identification of staining
when using digital images that was not observed with a
microscope was the use of correcting adjustments to the
image data during the digitising of TMAs. Bulbs used in
microscopes have a characteristic tint; in general this is
yellow or straw coloured. However, this tint is removed
when digitising slides using a corrective algorithm, poten-
tially unmasking weak staining that would otherwise be
attributable to background tint. Also, with microscope
based analysis, background light is adjusted to best suit
each individual spot. When digitising the slides for this
study, a constant background light intensity was used to
digitise all slides for this study.
Excluding nuclear staining, where positive staining was
infrequent, agreement levels were low when examining
staining intensity. When using a conventional micro-
scope, in general, users failed to utilise all grades within
the classifier to characterise positive staining intensity; the
category of moderate staining was repeatedly used when
positive staining was observed, particularly for membrane
staining. However, with digital reviews, all grades within
the classifier were utilised more extensively, which sug-
gests that the review of digital images gives a user more
confidence to discriminate between different intensities
and that subtle differences in intensity may be easier to
detect when utilising digital slides, than when utilising a
microscope. This may be due to the standardisation in
lighting while preparing the images.BMC Bioinformatics 2006, 7:256 http://www.biomedcentral.com/1471-2105/7/256
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Human observers, while excellent at object classification,
are inherently poor at quantifying intensities and areas to
any degree of accuracy. Studies have shown that image
analysis produces more reproducible results than pathol-
ogists for quantifying the intensity of staining, in relation
to β-Catenin expression in TMAs for colon cancer [22].
Image analysis systems may identify subtle differences in
staining intensity, which are not quantifiable by a human
reviewer, thus leading to the better correlation of expres-
sion data to prognostic indicators.
Conclusion
The virtual tissue matrix (VTM) was created to assist in
TMA analysis, by providing digital TMA images at multi-
ple magnifications online, and submitting TMA review
data from an online form into an associated database. The
VTM illustrated that digital TMA analysis obtained equiv-
alent levels of agreement as microscope based analysis, for
five out of eight parameters. The remaining three parame-
ters achieved greater levels of agreement when performed
using microscope analysis. However, on further investiga-
tion of the three parameters, it is proposed that the digital
reviews may be providing the user with greater capability
to accurately assess staining presence and intensity.
Results illustrated users were incapable of agreeing when
comparing digital and microscope TMA analysis when
classifying staining intensity. Greater levels of staining was
observed when performing digital TMA analysis, it is sug-
gested this is due to the background correction step
involved in digitising the slides.
Comparisons of digital with glass reviews of immunohis-
tochemistry stained slides is well documented in litera-
ture, however, in order to validate the VTM it was
necessary to perform this study. As previously reported in
literature, there was some degree of inter-and intra-
observer variability. However, the ability of users to
observe more positive staining when performing digital
reviews, and the inability of users to utilise all categories
within the classifiers provided when performing glass
reviews are previously unreported in literature.
Methods
Construction of TMAs
Forty eight bladder tumours which were part of a wider
study were utilized in this evaluation. Bladder cancer
TMAs were constructed from formalin-fixed paraffin-
embedded (FFPE) tissue blocks using a Beecher Instru-
ments® tissue arrayer. All FFPE blocks were sectioned and
stained with Haematoxylin and Eosin (H&E). Two cores
each of normal and tumour tissue where sampled. A total
of 6 TMAs were constructed, with 48 cases and 196 2 mm
cores, including 12 control spots composed of liver tissue.
Due to the heterogeneous nature of bladder tissue, 2 mm
cores were utilised. TMAs were sectioned at 4 µm and
probed with three antibodies, E-cadherin (Novocastra™),
β-Catenin (Labvision Corp., RB-9035-P1) and Phospho-
Met Tyr1234/1235 (Cell Signalling Technology, 3126S).
The method used was the Vectastain® ABC (avidin/biotin)
system (Vector Laboratories Inc, PK6200), with visualisa-
tion being accomplished by using DAB (3,3'-Diami-
nobenzidine tetrahydrochloride) as the chromogen. The
antibody to E-Cadherin shows membrane staining; the
antibody to β-Catenin shows membrane and cytoplasmic
staining [23], the antibody to Phospho met shows mem-
brane staining, cytoplasmic staining and nuclear staining
[24].
Construction of virtual TMAs
The imaging system was composed of an Olympus BX-40
microscope (Olympus, NY, USA) incorporating a Prior
H101 motorised stage. Images were captured at 4 × using
a Plan Achromat lens, and at 20 × using a Plan Fluorite
lens. The camera used to scan the immunostained TMAs
was a 3-chip JVC KY 55 B 3 CCD. The camera has a red,
green and blue (RGB) digital signal output to an Imaging
Technologies IC RGB frame grabber, (Coreco Imaging
Incorporated, MA, USA) which was housed in a Silicon
Graphics ZX10 imaging workstation. A software algo-
rithm was constructed using the Optimas development
environment (Media Cybernetics, MD, USA) that facili-
tated the remote control of the stage and the construction
of wide field-of-view images from a montage of smaller
fields. All software was written in-house. This facilitated
the development of a low cost method of image acquisi-
tion. Purchase of dedicated scanners for image acquisition
can often be prohibitively costly for research groups, and
this approach may present researchers with a low cost
solution to this issue.
TMAs were initially scanned at 4 × to create a tiled 'thumb-
nail' image of the entire array. This overview image was
used to locate cores manually through a custom Graphical
User Interface. The user clicked on the centre of each core
on the overview image and the coordinate generated was
used to seed an automatic scanning algorithm for all cores
at 20 ×. The array of captured images (6 × 8) were then
tiled together to form a montage bitmap image of approx-
imately 60.5 MB (4607 × 4592 pixels. 2.0 mm cores were
used as they illustrate the ability of the scanning system to
acquire and integrate multiple fields of view at 20 ×, a
large diameter of core was required as a smaller diameter
cores could potentially be captured within a single field.
The Macromedia Flash application, Zoomify™, was used
to display images within the VTM framework. Zoomify™
Droplet, a software tool provided by Zoomify™, uses the
original scanned BMP image as an input and converts it
into a set of JPEG image tiles [25]. This tileset, once
uploaded to a webserver, can be displayed via the InternetBMC Bioinformatics 2006, 7:256 http://www.biomedcentral.com/1471-2105/7/256
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using the Zoomify™-embedded object within a conven-
tional web page. Zoomify™ initially presents the user with
a low power view of each TMA spot. The users can then
scroll around the image and when required zoom into a
maximum magnification of 20×.
Validation of image quality
When using a lossy compression algorithm, such as JPEG,
image quality is reduced when compared with that of
uncompressed images. To ensure that the compression
rate used by Zoomify™ provided images of sufficient qual-
ity, a series of consultations with pathologists and scien-
tists were performed, where compressed and
uncompressed images were compared. The outcome of
this consultation was that the images generated by Zoom-
ify™ were suitable for scoring. Figure 2 illustrates the qual-
ity of images available in the VTM.
Design phase of the VTM
The design objectives of the VTM system were to provide
TMA images of sufficient quality to review over the World
Wide Web, to present scoring forms to record TMA results
and to create a relational database that can store and sub-
sequently retrieve data gathered during scoring.
PHP, Javascript, HTML and Oracle were used to create the
VTM. PHP is a server side scripting language, which creates
dynamic web pages, through embedding PHP code in
HTML pages. Through the use of SQL queries, it can also
extract data from many conventional databases (Oracle,
MySQL, etc). Javascript adds interactive client side func-
tionality to otherwise static HTML pages [26]. An Oracle
relational database was used to store all the information
generated in this study [27].
Database design
The construction of TMAs facilitates the generation of
hundreds of TMA slides from a single TMA block; there-
fore every TMA slide produced has the ability to be stained
with a unique immunostain. A major benefit of storing
TMA images and results within a relational database is the
ability to extract all the results associated with a single
Digital image of TMA spot presented in VTM using Zoomify™ application Figure 2
Digital image of TMA spot presented in VTM using Zoomify™ application. On the top left corner of image is the 
thumbnail overview; the red box identifies location within the spot. The key at the bottom of the image allows the user to 
change position or magnification, which can also be controlled by the cursor.BMC Bioinformatics 2006, 7:256 http://www.biomedcentral.com/1471-2105/7/256
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core, which potently may have been immunostained hun-
dreds of times. This functionality is available within the
VTM.
Based on analysis of conventional TMA datasets, it was
established that eleven groupings of data would be suffi-
cient to record all relevant information; therefore, eleven
tables where created in the VTM relational database. Each
table contains information relating to a specific aspect of
a TMA review. For example, the USER table contains infor-
mation relating to users only; SCORES table contains
information relating to the TMA analysis results only. A
unique identifier interlinks all tables and by using SQL
statements, information can be retrieved from multiple
tables simultaneously. For example, results relating to a
specific user can be obtained by creating an SQL statement
that requests information from the SCORES and USER
tables. Table 2 lists all the tables that exist in the database
and examples of the information they record. A complete
schema of the database is available [28] and also as Addi-
tional file 1.
The database has been designed to eliminate replication
of data input. For example, a manufacturer of TMAs
details are only entered into the database once regardless
of the number of TMAs they have constructed, once their
account is created they can be associated with multiple
blocks/slides and studies. There is also the ability to add
information into the database after the initial study has
been created. For example, if patient or biopsy informa-
tion is not known at the time of entering the TMA review
results into the database, they may be entered at a later
date, by simply entering the patient or biopsy information
and then selecting the cores the information applies to.
However, users are unable to overwrite the TMA review
results already present in the database.
Depending on the internet connection used (times
described here are for LAN settings of 10 Mbps), it takes
approx 5 seconds to download the thumbnail overview of
a TMA slide; once a core has been selected it takes approx
2–3 seconds to view the individual core in the Zoomify ™
window. There are no restrictions on the number of
images that can be displayed within the VTM, currently
there are 196 images. However, the number of images dis-
played is dependent on the capacity of the server available
to the users.
Interface design
The user interface had to be easily navigated, interpretable
and provide images at sufficient speed and resolution for
review. There are two types of user account within the
VTM, namely administrator or user. A user has restricted
access to the site; they can only review and score images.
An administrator has additional privileges within the site;
they can create new studies, add new images and scoring
forms and can view all data stored in the database.
The VTM was constructed so the user is lead through the
site, not having to concentrate on the sequence of events,
freeing up analysis time for the reviewing process. Figure
3 illustrates the options available to both user and admin-
istrator within the VTM. Figure 4 illustrates the user's view
of a TMA slide before a specific spot is selected. A spot
must be clicked on to view a scaleable image. Once
selected, the spot is reviewed in a pop-up window and the
option to record results via a scoring form is presented.
Figure 5 illustrates the spot with the associated scoring
form. The administrator has the ability to create new scor-
ing forms depending on the user's specifications.
Users, scales and parameters recorded
Two pathologists and one research scientist scored the
immunohistochemically stained TMA slides. One of the
former was an external examiner, completing a virtual
review of one slide from an international location. This
review was conducted to ensure the VTM functioned in a
remote location and to ensure that a user who had no con-
tribution to the design phase could use the VTM software
system. As a result of having only one data set from this
Table 2: Tables within the VTM database and examples of their content.
Table Name Information held Examples
User User details E-mail address
TMA Manufacturer Manufacturer details Name
TMA Tissue Microarrays Diagram of cores
Patient Patient information Gender
Biopsy Biopsy details Biopsy notes
Core Core details Tissue type
Spot Spots in a slide Magnification scanned
Experiment Slide Experiment procedure Treatment name
Slide scoring range Scoring ranges Staining category
Score Results Amt of Nuclear staining
Intensity Table Staining intensity details Staining typeBMC Bioinformatics 2006, 7:256 http://www.biomedcentral.com/1471-2105/7/256
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user, their observations were not included in the results
that follow.
Review methods included a glass slide review and a virtual
slide review. The glass slide review was a traditional
microscope-based process; the virtual review was per-
formed over the World Wide Web using the VTM. Eight
parameters were examined for each spot. The amount and
intensity of membrane, cytoplasmic and nuclear staining,
as well as the amount of core and tumour present in each
spot, were recorded. A five-point scale was used to record
the staining intensity. Within the five-point scale, grade 0
represented negative staining, grade 1 was weak staining,
grade 2 was moderate staining and grade 3 was strong
staining. Grade 4 was included to record variable staining;
this option was only available when scoring membrane
staining.
A four-point scale was used to record the amount of stain-
ing present in tumour-containing regions of each spot.
Grade 0 represented no staining, grade 1 represented 1–
30% of relevant cells staining, grade 2 represented 31–
50% staining and grade 3 represented greater than 50%
staining. An eleven-point scale was used to record the
amount of core and tumour present. Grade 0 was nega-
tive/no tissue, and grade 1 to 10 increased in 10% incre-
ments to 100%.
Cohen's un-weighted Kappa
Cohen's un-weighted kappa values were one of two meth-
ods used to quantify the level of agreements achieved
when comparing two datasets generated from TMA
reviews. Kappa was not the primary statistics used in the
dataset comparisons involved in this study, however;
Kappa has been included as it is widely used in compari-
sons of observer agreement of this type. Landis and Koch
kappa interpretation scale was used to evaluate the level of
kappa agreements; the interpretation scale is illustrated in
Table 3[29]. The predominant method used to quantify
the levels of agreement achieved when comparing two
datasets generated from TMA reviews, was the percentage
of cases where the two datasets were in complete agree-
ment.
Abbreviations
TMA-tissue microarray
TMAs-tissue microarrays
VTM-virtual tissue matrix
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0.2–0.4 Fair
0.4–0.6 Moderate
0.6–0.8 Substantial
0.8–1.00 Almost Perfect
Ranges of Cohen's Kappa values.
Options available to users through the VTM interface Figure 3
Options available to users through the VTM inter-
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istrators and Users within the VTM interface.BMC Bioinformatics 2006, 7:256 http://www.biomedcentral.com/1471-2105/7/256
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Availability and requirements
The Virtual Tissue Matrix can be found at http://
www.telepathology.dcu.ie/VTM. Operating system(s):
Platform independent; Programming language used
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include Macromedia flash version 7. The source code of
the VTM is available at Additional file 2.
Overview of digital TMA slide as presented in the VTM interface Figure 4
Overview of digital TMA slide as presented in the VTM interface. Clicking on any spot will result in an enlarged ver-
sion of the spot being provided, as in Figure 5.BMC Bioinformatics 2006, 7:256 http://www.biomedcentral.com/1471-2105/7/256
Page 11 of 12
(page number not for citation purposes)
Additional material
Acknowledgements
For more information on the VTM readers can log into the site using User-
name, VTM and Password, VTM [30]. The authors would like to thank the 
pathologists and scientists who participated in this study. WMG and SOB 
would like to acknowledge Cancer Research Ireland and the Health 
Research Board for funding. This project was also facilitated by the Marie 
Curie Transfer of Knowledge Industry-Academia Partnership research pro-
gramme, TargetBreast http://www.targetbreast.com.
References
1. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P,
Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue
microarrays for high-throughput molecular profiling of
tumor specimens.  Nat Med 1998, 4:844-847.
2. Sharma-Oates A, Quirke P, Westhead DR: TmaDB: a repository
for tissue microarray data.  BMC Bioinformatics 2005, 6:218.
3. Manley S, Mucci NR, De Marzo AM, Rubin MA: Relational database
structure to manage high-density tissue microarray data and
images for pathology studies focusing on clinical outcome:
the prostate specialized program of research excellence
model.  Am J Pathol 2001, 159:837-843.
4. Liu CL, Prapong W, Natkunam Y, Alizadeh A, Montgomery K, Gilks
CB, van de Rijn M: Software tools for high-throughput analysis
and archiving of immunohistochemistry staining data
obtained with tissue microarrays.  Am J Pathol 2002,
161:1557-1565.
5. Bova GS, Parmigiani G, Epstein JI, Wheeler T, Mucci NR, Rubin MA:
Web-based tissue microarray image data analysis: initial val-
idation testing through prostate cancer Gleason grading.
Hum Pathol 2001, 32:417-427.
6. Johnston DJ, Costello SP, Dervan PA, O'Shea DG: Development
and preliminary evaluation of the VPS ReplaySuite: a virtual
double-headed microscope for pathology.  BMC Med Inform
Decis Mak 2005, 5:10.
7. Hoang MP, Sahin AA, Ordonez NG, Sneige N: HER-2/neu gene
amplification compared with HER-2/neu protein overex-
Additional File 1
A complete schema of the database structure, and lists all the tables and 
entries within the tables.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-7-256-S1.bmp]
Additional File 2
Source code for the VTM site and database
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-7-256-S2.zip]
Scoring form presented to users within the VTM interface Figure 5
Scoring form presented to users within the VTM interface. Results can be entered into the scoring form on the left, 
the image can be magnified and scrolling is possible via the controls provided.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Bioinformatics 2006, 7:256 http://www.biomedcentral.com/1471-2105/7/256
Page 12 of 12
(page number not for citation purposes)
pression and interobserver reproducibility in invasive breast
carcinoma.  Am J Clin Pathol 2000, 113:852-859.
8. Ellis CM, Dyson MJ, Stephenson TJ, Maltby EL: HER2 amplification
status in breast cancer: a comparison between immunohis-
tochemical staining and fluorescence in situ hybridisation
using manual and automated quantitative image analysis
scoring techniques.  J Clin Pathol 2005, 58:710-714.
9. Gomez DD, Carstensen JM, Ersboll BK: Collecting highly repro-
ducible images to support dermatological medical diagnosis.
Image and Vision Computing 2006, 24:186-191.
10. Stelldinger P, Kothe U: Connectivity preserving digitization of
blurred binary images in 2D and 3D.  Computers & Graphics-Uk
2006, 30:70-76.
11. Yasuda N, Namiki K, Honma Y, Umeshima Y, Marumo Y, Ishii H, Ben-
ton ER: Development of a high speed imaging microscope and
new software for nuclear track detector analysis.  Radiation
Measurements 2005, 40:311-315.
12. Warford A, Howat W, McCafferty J: Expression profiling by high-
throughput immunohistochemistry.  J Immunol Methods 2004,
290:81-92.
13. Ho J, Parwani AV, Jukic DM, Yagi Y, Anthony L, Gilbertson JR: Use
of  whole slide imaging in surgical pathology quality assur-
ance: design  and pilot validation studies.  Hum Pathol 2006,
37:322-31.
14. Hansen WH, Gilman G, Finnesgard SJ, Wellik TJ, Nelson TA, Johnson
MF, Schwenk NM, Seward JB, Khandheria BK: The transition from
an analog to a digital echocardiography laboratory: The
Mayo experience.  Journal of the American Society of Echocardiography
2004, 17:1214-1224.
15. Patton N, Aslam TM, MacGillivray T, Deary IJ, Dhillon B, Eikelboom
RH, Yogesan K, Constable IJ: Retinal image analysis: Concepts,
applications and potential.  Prog Retin Eye Res 2006, 25:99-127.
16. McCullough B, Ying X, Monticello T, Bonnefoi M: Digital micros-
copy imaging and new approaches in toxicologic pathology.
Toxicol Pathol 2004, 32 Suppl 2:49-58.
17. Della Mea V, Viel F, Beltrami CA: A pixel-based autofocusing
technique for digital histologic and cytologic slides.  Comput
Med Imaging Graph 2005, 29:333-341.
18. Weinstein RS, Descour MR, Liang C, Barker G, Scott KM, Richter L,
Krupinski EA, Bhattacharyya AK, Davis JR, Graham AR, et al.: An
array microscope for ultrarapid virtual slide processing and
telepathology. Design, fabrication, and validation study.  Hum
Pathol 2004, 35:1303-1314.
19. Aperio Technologies   [http://www.aperio.com/]
20. D.metrix   [http://www.dmetrix.net/]
21. Applied Imaging   [http://www.aicorp.com/]
22. Camp RL, Chung GG, Rimm DL: Automated subcellular localiza-
tion and quantification of protein expression in tissue micro-
arrays.  Nat Med 2002, 8:1323-1327.
23. Wijnhoven BP, Dinjens WN, Pignatelli M: E-cadherin-catenin cell-
cell adhesion complex and human cancer.  Br J Surg 2000,
87:992-1005.
24. Moran E, Larkin A, Doherty G, Kelehan P, Kennedy S, Clynes M: A
new mdr-1 encoded P-170 specific monoclonal antibody: (6/
1C) on paraffin wax embedded tissue without pretreatment
of sections.  J Clin Pathol 1997, 50:465-471.
25. Zoomify Homepage   [http://www.zoomify.com/ez/]
26. PHP Homepage   [http://www.php.net/]
27. Oracle Homepage   [http://www.oracle.com]
28. Details of VTM Database tables   [http://www.telepathol
ogy.dcu.ie/VTM/Diagram/TableDetails.bmp]
29. Landis JR, Koch GG: The measurement of observer agreement
for categorical data.  Biometrics 1977, 33:159-174.
30. VTM   [http://www.telepathology.dcu.ie/VTM/]